What is a stock summary page? Click here for an overview.
Business Description
Eledon Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US67011N1054
Description
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 156.07 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 46.1 | |||||
| 3-Year EPS without NRI Growth Rate | 51.3 | |||||
| 3-Year FCF Growth Rate | 46.5 | |||||
| 3-Year Book Growth Rate | -71.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.97 | |||||
| 9-Day RSI | 41.4 | |||||
| 14-Day RSI | 39.53 | |||||
| 3-1 Month Momentum % | -2.58 | |||||
| 6-1 Month Momentum % | 65.08 | |||||
| 12-1 Month Momentum % | 106.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.53 | |||||
| Quick Ratio | 6.53 | |||||
| Cash Ratio | 6.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.9 | |||||
| Shareholder Yield % | -25.88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -44.97 | |||||
| ROA % | -21.62 | |||||
| ROIC % | -158.52 | |||||
| 3-Year ROIIC % | 59.76 | |||||
| ROC (Joel Greenblatt) % | -4903.96 | |||||
| ROCE % | -59.62 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.95 | |||||
| Price-to-Tangible-Book | 3.41 | |||||
| EV-to-EBIT | -1.87 | |||||
| EV-to-EBITDA | -1.88 | |||||
| EV-to-Forward-Revenue | 0.17 | |||||
| EV-to-FCF | -3.42 | |||||
| Price-to-Net-Current-Asset-Value | 3.47 | |||||
| Price-to-Net-Cash | 3.76 | |||||
| Earnings Yield (Greenblatt) % | -53.48 | |||||
| FCF Yield % | -21.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ELDN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eledon Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.05 | ||
| Beta | 0.93 | ||
| 3-Year Sharpe Ratio | 0.37 | ||
| 3-Year Sortino Ratio | 0.72 | ||
| Volatility % | 91.8 | ||
| 14-Day RSI | 39.53 | ||
| 14-Day ATR ($) | 0.214656 | ||
| 20-Day SMA ($) | 3.78175 | ||
| 12-1 Month Momentum % | 106.97 | ||
| 52-Week Range ($) | 1.52 - 5.54 | ||
| Shares Outstanding (Mil) | 59.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eledon Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eledon Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eledon Pharmaceuticals Inc Frequently Asked Questions
What is Eledon Pharmaceuticals Inc(ELDN)'s stock price today?
The current price of ELDN is $3.61. The 52 week high of ELDN is $5.54 and 52 week low is $1.52.
When is next earnings date of Eledon Pharmaceuticals Inc(ELDN)?
The next earnings date of Eledon Pharmaceuticals Inc(ELDN) is 2025-03-28 Est..
Does Eledon Pharmaceuticals Inc(ELDN) pay dividends? If so, how much?
Eledon Pharmaceuticals Inc(ELDN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers